Look no further than the NYTimes (linked here by Legal Insurrection.)
$700 MILLION at risk. If the drug works, Roche makes a lot of money.
If it does not, they'll kiss that $700MM buh-bye.
Of interest only if you or a loved one has melanoma, by the way...
Subscribe to: Post Comments (Atom)
Post a Comment